Jan. 7 at 1:37 PM
$RYOJ Pancreas optionality is not hand waving, it’s numbers plus process, 285 subjects including 35 cancers at 95% sensitivity 98% specificity, 18 biomarkers evaluated to streamline, leading panel at 100% sensitivity 95% specificity in 30, and a pathway aiming at future FDA applications, that’s how serious programs get built